In stock
MOTS-C
Metabolic
Metabolic
£29.99
Free 24-hour delivery over £75 · Same-day dispatchOrder before 2pm - same-day dispatch · Free 24-hour delivery over £75
Metabolic
- MOTS-C
£29.99
Sold outAOD-9604AOD-9604
Metabolic
Metabolic
£37.99
£37.99
Sold outHGH Fragment 176-191HGH Fragment 176-191
Metabolic
Metabolic
£27.99
£27.99
What are metabolic research peptides?
"Metabolic research peptides" is a taxonomy label Kovalabs uses to group reference compounds that appear in the published metabolic and incretin research literature. It is the name of a research area these materials are studied in, not a benefit or outcome Kovalabs claims or implies for any of them. The group brings together compounds investigated for their roles in incretin, amylin, and mitochondrial metabolic pathways in non-clinical model systems. The Kovalabs metabolic range includes Retatrutide, Cagrilintide, MOTS-c, AOD-9604, and HGH Fragment 176-191. Each is supplied as a lyophilised solid for laboratory research only, and each has its own product page with molecular formula, CAS number, and sourcing detail.
What does the research investigate?
These compounds appear in the published metabolic-pathway and incretin research literature in pre-clinical and in-vitro models: Retatrutide and Cagrilintide in incretin and amylin receptor signalling, MOTS-c in mitochondrial metabolism and the AMPK pathway, and AOD-9604 and HGH Fragment 176-191 in lipolytic and metabolic-pathway activity. None of that work establishes a benefit, effect, or outcome in humans. Nothing here is a medical claim, and none of these materials is a licensed medicine. Retatrutide and Cagrilintide are investigational compounds under study; they are not offered as, equivalent to, or a substitute for any medicine or treatment.
Are these legal in the UK?
The compounds grouped here are not controlled drugs under the Misuse of Drugs Act 1971. Kovalabs supplies them strictly for laboratory research use only: they are not for human or veterinary consumption, and they are not medicines, supplements, or cosmetics. The buyer is responsible for handling, storing, and using any material lawfully and for confirming that its intended research use complies with the regulations applying to their institution and jurisdiction. See the research disclaimer for the full terms that apply to every order.
How does Kovalabs assure quality?
Every batch across the metabolic range is released only after independent identity and purity testing. Purity is assessed by HPLC, with materials supplied to a 99% specification, and identity is confirmed against the expected mass. A per-batch certificate of analysis (CoA) is available for each compound, and orders are despatched from the UK. You can review the published certificates on the CoAs page, where each report is matched to its compound and batch so a buyer can verify what they have received.
Where to start
To identify the right reference compound, read each member's product page for its molecular detail and documented research context: Retatrutide, Cagrilintide, MOTS-c, AOD-9604, and HGH Fragment 176-191. You can also browse the full metabolic category or the wider Kovalabs store.
Common questions
- What are metabolic research peptides?
- It is a taxonomy label Kovalabs uses to group reference compounds that appear in the published metabolic and incretin research literature. The name describes a research area these materials are studied in, not a benefit or outcome. The group covers compounds investigated in incretin, amylin, and mitochondrial metabolic pathways in non-clinical model systems only.
- Which compounds are in the metabolic category?
- The Kovalabs metabolic range groups Retatrutide, Cagrilintide, MOTS-c, AOD-9604, and HGH Fragment 176-191. Each is supplied as a lyophilised solid for laboratory research only and has its own product page listing its molecular formula, CAS number, and documented research context. Each is sold individually; Kovalabs does not suggest combining or comparing them for any goal.
- Are these peptides legal to buy in the UK?
- The compounds grouped here are not controlled drugs under the Misuse of Drugs Act 1971. Kovalabs supplies them strictly for laboratory research use only, not for human or veterinary consumption, and they are not medicines, supplements, or cosmetics. The buyer is responsible for lawful handling and for confirming their intended research use complies with applicable regulations.
- Are metabolic research peptides for human use?
- No. None of these materials is intended or supplied for human or veterinary use, and no human application is intended or implied. They are reference compounds for non-clinical laboratory research only. Nothing on this page is a medical claim, and none of the compounds is a licensed medicine. The published research does not establish any benefit, effect, or outcome in humans.
- How is quality assured and is a CoA provided?
- Every batch is released only after independent identity and purity testing. Purity is assessed by HPLC to a 99% specification and identity is confirmed against the expected mass. A per-batch certificate of analysis (CoA) is available for each compound, published on the CoAs page and matched to its batch, and orders are despatched from the UK.
- How do I choose between the compounds in this category?
- Selection depends on which research pathway a compound is documented in, not on any outcome. Read each product page: Retatrutide and Cagrilintide sit in incretin and amylin receptor research, MOTS-c in mitochondrial metabolism and the AMPK pathway, and AOD-9604 and HGH Fragment 176-191 in lipolytic and metabolic-pathway research. Kovalabs does not recommend one compound as best for any purpose.
- What is the difference between Retatrutide and Cagrilintide?
- They are distinct compounds with different molecular identities studied in different receptor pathways. Retatrutide is studied in research into multi-incretin receptor signalling, while Cagrilintide is studied in amylin receptor research. Both are investigational compounds and neither is a licensed medicine. Confirm identity for each by its CAS number, molecular formula, and per-batch CoA on its product page.
- Are Retatrutide and Cagrilintide medicines?
- No. Retatrutide and Cagrilintide are investigational compounds studied in the published research literature; they are not licensed medicines and are not offered as, equivalent to, or a substitute for any medicine or treatment. Kovalabs supplies them as reference materials for non-clinical laboratory research only, not for human or veterinary use.